Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome

Brain Research

Volumn 1394, Issue , 2011, Pages 90-104

  Alves, Chrystian Junqueira ^a   De Santana, Luana Pereira ^a   Dos Santos, Angélica Janaína Dias ^a   De Oliveira, Gabriela Pintar ^a   Duobles, Tatiana ^a   Scorisa, Juliana Milani ^a   Martins, Roberto Sérgio ^a   Maximino, Jessica Ruivo ^a   Chadi, Gerson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amyotrophic lateral sclerosis; Electrophysiology; Footprint; Mutant SOD1G93A Early motor impairments; Tail elevation gender

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; FEMALE; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; NERVE CONDUCTION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROFILAMENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCIATIC NERVE; SURVIVAL TIME; TRANSGENIC ANIMAL; TREMOR;

ACTION POTENTIALS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROPHYSIOLOGY; FEMALE; MALE; MICE; MICE, TRANSGENIC; SEX CHARACTERISTICS; SUPEROXIDE DISMUTASE;

MUS; MUS MUSCULUS;

EID: 79956266554     PISSN: 00068993     EISSN: 00068993     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.02.060     Document Type: Article

References (49)

1. Andersen, P.M., 2004. The genetics of amyotrophic lateral sclerosis (ALS). Suppl. Clin. Neurophysiol. 57, 211-227.
2. Andrade, M.S., Mendonca, L.M., Chadi, G., 2010. Treadmill running protects spinal cord contusion from secondary degeneration. Brain Res. 1346, 266-278.
3. Azzouz, M., Leclerc, N., Gurney, M., Warter, J.M., Poindron, P., Borg, J., 1997. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve 20, 45-51. (Pubitemid 27009468)
4. Barneoud, P., Lolivier, J., Sanger, D.J., Scatton, B., Moser, P., 1997. Quantitative motor assessment in FALS mice: a longitudinal study. NeuroReport 8, 2861-2865. (Pubitemid 27394808)
5. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Brooks, S.P., Dunnett, S.B., 2009. Tests to assess motor phenotype in mice: a user's guide. Nat. Rev. Neurosci. 10, 519-529.
7. Browne, S.E., Yang, L., DiMauro, J.P., Fuller, S.W., Licata, S.C., Beal, M.F., 2006. Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol. Dis. 22, 599-610.
8. Bruijn, L.I., Miller, T.M., Cleveland, D.W., 2004. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723-749.
9. Chadi, G., Moller, A., Rosen, L., Janson, A.M., Agnati, L.A., Goldstein, M., Ogren, S.O., Pettersson, R.F., Fuxe, K., 1993. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Exp. Brain Res. 97, 145-158.
10. Chadi, G., Andrade, M.S., Leme, R.J., Gomide, V.C., 2001. Experimental models of partial lesion of rat spinal cord to investigate neurodegeneration, glial activation, and behavior impairments. Int. J. Neurosci. 111, 137-165.
11. Chadi, G., Silva, C., Maximino, J.R., Fuxe, K., da Silva, G.O., 2008. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain. Brain Res. 1190, 23-38.
12. Chen, K., et al., 2010. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Brain Struct. Funct. 214, 219-234.
13. Chiu, A.Y., Zhai, P., Dal Canto, M.C., Peters, T.M., Kwon, Y.W., Prattis, S.M., Gurney, M.E., 1995. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6, 349-362.
14. Choi, C.I., Lee, Y.D., Gwag, B.J., Cho, S.I., Kim, S.S., Suh-Kim, H., 2008. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J. Neurol. Sci. 268, 40-47.
15. Dal Canto, M.C., Gurney, M.E., 1997. A low expressor line of transgenic mice carrying a mutant human Cu, Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol. 93, 537-550. (Pubitemid 27239242)
16. Dijkstra, J.R., Meek, M.F., Robinson, P.H., Gramsbergen, A., 2000. Methods to evaluate functional nerve recovery in adult rats: walking track analysis, video analysis and the withdrawal reflex. J. Neurosci. Methods. 96, 89-96.
17. Dumitru, D., DeLisa, J.A., 1991. AAEM Minimonograph #10: volume conduction. Muscle Nerve 14, 605-624.
18. Dunham, N.W., Miya, T.S., 1957. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. Am. Pharm. Assoc. Baltim. 46, 208-209.
19. Durand, J., Amendola, J., Bories, C., B., Lamotte d'Incamps, 2006. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis. J. Physiol. Paris 99, 211-220.
20. Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M.A., Glass, J.D., 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240.
21. Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., Caroni, P., 2000. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20, 2534-2542. (Pubitemid 30220340)
22. Gomide, V.C., Chadi, G., 2004. Prenatal ethanol enhances rotational behavior to apomorphine in the 24-month-old rat offspring with small striatal lesion. Neurotoxicol. Teratol. 26, 417-427.
23. Guillot, T.S., Asress, S.A., Richardson, J.R., Glass, J.D., Miller, G.W., 2008. Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. J. Mot Behav. 40, 568-577.
24. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.X., et al., 1994. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775. (Pubitemid 24227760)
25. Guzen, F.P., de Almeida Leme, R.J., de Andrade, M.S., de Luca, B.A., Chadi, G., 2009. Glial cell line-derived neurotrophic factor added to a sciatic nerve fragment grafted in a spinal cord gap ameliorates motor impairments in rats and increases local axonal growth. Restor. Neurol. Neurosci. 27, 1-16.
26. Hayworth, C.R., Gonzalez-Lima, F., 2009. Pre-symptomatic detection of chronicmotor deficits and genotype prediction in congenic B6. SOD1(G93A) ALS mouse model. Neuroscience 164, 975-985.
27. Hegedus, J., Putman, C.T., Gordon, T., 2009. Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender. Muscle Nerve 39, 318-327.
28. Heiman-Patterson, T.D., Deitch, J.S., Blankenhorn, E.P., Erwin, K.L., Perreault, M.J., Alexander, B.K., Byers, N., Toman, I., Alexander, G.M., 2005. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J. Neurol. Sci. 236, 1-7.
29. Ince, P.G., Lowe, J., Shaw, P.J., 1998. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol. Appl. Neurobiol. 24, 104-117.
30. Kennel, P.F., Finiels, F., Revah, F., Mallet, J., 1996. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. NeuroReport 7, 1427-1431. (Pubitemid 26281007)
31. Kirkinezos, I.G., Hernandez, D., Bradley, W.G., Moraes, C.T., 2003. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 53, 804-807.
32. Knippenberg, S., Thau, N., Dengler, R., Petri, S., 2010. Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav. Brain Res. 213, 82-87.
33. Miana-Mena, F.J., Munoz, M.J., Yague, G., Mendez, M., Moreno, M., Ciriza, J., Zaragoza, P., Osta, R., 2005. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph. Lateral Scler. Other Mot. Neuron. Disord. 6, 55-62.
34. Niessen, H.G., Debska-Vielhaber, G., Sander, K., Angenstein, F., Ludolph, A.C., Hilfert, L., Willker, W., Leibfritz, D., Heinze, H.J., Kunz, W.S., Vielhaber, S., 2007. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 25, 1669-1677.
35. Niimi, K., Takahashi, E., 2009. Combination of modified SHIRPA and pharmacological approach uncovers neuronal alteration in senescence-accelerated mouse prone 6 (SAMP6) strain. Neurosci. Lett. 458, 53-56.
36. Riederer, B.M., et al., 1996. Differential expression and modification of neurofilament triplet proteins during cat cerebellar development. J. Comp. Neurol. 364, 704-717.
37. Ringer, C., Weihe, E., Schutz, B., 2009. Pre-symptomatic alterations in subcellular betaCGRP distribution in motor neurons precede astrogliosis in ALS mice. Neurobiol. Dis. 35, 286-295.
38. Rogers, D.C., Fisher, E.M., Brown, S.D., Peters, J., Hunter, A.J., Martin, J.E., 1997. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 8, 711-713. (Pubitemid 127739700)
39. Rosen, D.R., 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364, 362. (Pubitemid 23265284)
40. Schlaepfer, W.W., Bruce, J., 1990. Simultaneous up-regulation of neurofilament proteins during the postnatal development of the rat nervous system. J. Neurosci. Res. 25, 39-49.
41. Scorisa, J.M., Duobles, T., de Oliveira, G.P., Maximino, J.R., Chadi, G., 2010. The review of the methods to obtain non-neuronal cells to study glial influence on amyotrophic lateral sclerosis pathophysiology at molecular level in vitro. Acta Cir. Bras. 25, 281-289.
42. Shefner, J.M., Cudkowicz, M.E., Brown Jr., R.H., 2002. Comparison of incremental with multipoint MUNE methods in transgenic ALS mice. Muscle Nerve 25, 39-42.
43. Silva, C., Fuxe, K., Chadi, G., 2009. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair. J. Neural Transm. Suppl. 185-202.
44. Smittkamp, S.E., Brown, J.W., Stanford, J.A., 2008. Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice. Neuroscience 151, 613-621.
45. Suzuki, N., Mizuno, H., Warita, H., Takeda, S., Itoyama, Y., Aoki, M., 2010. Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis. J. Neurol. Sci. 294, 95-101.
46. Veldink, J.H., Bar, P.R., Joosten, E.A., Otten, M., Wokke, J.H., van den Berg, L.H., 2003. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 13, 737-743.
47. Weydt, P., Hong, S.Y., Kliot, M., Moller, T., 2003. Assessing disease onset and progression in the SOD1 mouse model of ALS. NeuroReport 14, 1051-1054. (Pubitemid 36829789)
48. Yang, W.W., et al., 2011. Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse. Exp Neurol. 227, 287-295.
49. Yim, M.B., Kang, J.H., Yim, H.S., Kwak, H.S., Chock, P.B., Stadtman, E.R., 1996. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu. Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl Acad. Sci. USA 93, 5709-5714.